Baidu
map

指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

2021 SNIS报告：特殊人群血栓切除术

2021-07-08 美国神经介入外科学会 J Neurointerv Surg. 2021 Jul 8;

血栓切除

本文主要总结了特殊人群（包括儿童、老年人、孕妇以及近期接受过手术的患者、血小板减少症等）进行机械血栓切除术（MT）治疗紧急大血管闭塞（ELVO）的相关数据并提出指导建议。

中文标题：

2021 SNIS报告：特殊人群血栓切除术

英文标题：

Thrombectomy in special populations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee

发布机构：

美国神经介入外科学会

发布日期：

2021-07-08

简要介绍：

本文主要总结了特殊人群（包括儿童、老年人、孕妇以及近期接受过手术的患者、血小板减少症等）进行机械血栓切除术（MT）治疗紧急大血管闭塞（ELVO）的相关数据并提出指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 SNIS报告：特殊人群血栓切除术.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8efb31c00213514b, title=2021 SNIS报告：特殊人群血栓切除术, enTitle=Thrombectomy in special populations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee, guiderFrom=J Neurointerv Surg. 2021 Jul 8;, authorId=0, author=, summary=本文主要总结了特殊人群（包括儿童、老年人、孕妇以及近期接受过手术的患者、血小板减少症等）进行机械血栓切除术（MT）治疗紧急大血管闭塞（ELVO）的相关数据并提出指导建议。, cover=https://img.medsci.cn/2021724/1627127618204_2020535.jpg, journalId=0, articlesId=null, associationId=42, associationName=美国神经介入外科学会, associationIntro=美国神经介入外科学会创立于1992年，是一个科学教育学会，有600个全球成员。该学会致力于推进神经介入手术，向公众提供最高质量的病人护理。其官方期刊是Journal of NeuroInterventional Surgery, copyright=0, guiderPublishedTime=Thu Jul 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>本文主要总结了特殊人群（包括儿童、老年人、孕妇以及近期接受过手术的患者、血小板减少症等）进行机械血栓切除术（MT）治疗紧急大血管闭塞（ELVO）的相关数据并提出指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2483, tagName=血栓切除)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2483, guiderKeyword=血栓切除, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5957, appHits=43, showAppHits=0, pcHits=267, showPcHits=5914, likes=1, shares=5, comments=3, approvalStatus=1, publishedTime=Sat Jul 24 21:38:06 CST 2021, publishedTimeString=2021-07-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 24 19:53:50 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 05:04:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SNIS报告：特殊人群血栓切除术.pdf)])
2021 SNIS报告：特殊人群血栓切除术.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1014176, encodeId=43f610141e681, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Sep 03 08:09:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004604, encodeId=e0841004604e1, content=非常好，已收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5f5c0e7163464740bc5e2042b97ffa1f/dd2b0c2962de4cb396107777a06285ee.jpg, createdBy=4e7b2441913, createdName=123d84e1m24暂无昵称, createdTime=Mon Aug 02 12:10:29 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002599, encodeId=9433100259901, content=非常好，已收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/1c9b7868e8934ac89182276c365a4b8f/c48b12776a094c9784d2052f3f4c14f0.jpg, createdBy=9f8e5556656, createdName=mashumin168, createdTime=Sun Jul 25 22:23:29 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-09-03 huihui0728

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1014176, encodeId=43f610141e681, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Sep 03 08:09:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004604, encodeId=e0841004604e1, content=非常好，已收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5f5c0e7163464740bc5e2042b97ffa1f/dd2b0c2962de4cb396107777a06285ee.jpg, createdBy=4e7b2441913, createdName=123d84e1m24暂无昵称, createdTime=Mon Aug 02 12:10:29 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002599, encodeId=9433100259901, content=非常好，已收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/1c9b7868e8934ac89182276c365a4b8f/c48b12776a094c9784d2052f3f4c14f0.jpg, createdBy=9f8e5556656, createdName=mashumin168, createdTime=Sun Jul 25 22:23:29 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-08-02 123d84e1m24暂无昵称

    非常好，已收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1014176, encodeId=43f610141e681, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Fri Sep 03 08:09:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004604, encodeId=e0841004604e1, content=非常好，已收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210802/5f5c0e7163464740bc5e2042b97ffa1f/dd2b0c2962de4cb396107777a06285ee.jpg, createdBy=4e7b2441913, createdName=123d84e1m24暂无昵称, createdTime=Mon Aug 02 12:10:29 CST 2021, time=2021-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002599, encodeId=9433100259901, content=非常好，已收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/1c9b7868e8934ac89182276c365a4b8f/c48b12776a094c9784d2052f3f4c14f0.jpg, createdBy=9f8e5556656, createdName=mashumin168, createdTime=Sun Jul 25 22:23:29 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-07-25 mashumin168

    非常好，已收藏

    0

Baidu
map
Baidu
map
Baidu
map